SVF ENDURANCE (CAYMAN) LTD sold 3.1% of their position (524.30K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $2.92M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/7/2025ACC: 0001493152-25-017300
10% Owner
Since Oct 2019
-524.30K
Net shares
Net seller
$2.92M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
524.30K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−450.34K
Price / share
$5.56
Trade value
$2.50M
% of position
2.7%
10/3/2025
16.68M→16.23M
Common Stock
Indirect
Shares
−73.95K
Price / share
$5.69
Trade value
$420.64K
% of position
0.5%
10/6/2025
16.23M→16.16M
Total
Net shares
−524.30K
Net value
-$2.92M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/3/2025 | S · Sale | −450.34K | $5.56 | $2.50M | 2.7% | 16.68M | 16.23M |
| Common Stock Indirect | 10/6/2025 | S · Sale | −73.95K | $5.69 | $420.64K | 0.5% | 16.23M | 16.16M |
| Total | −524.30K | -$2.92M | ||||||
Derivative Transactions0
No derivative transactions reported